DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 204822
, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the IZBA profile page.
The generic ingredient in IZBA is travoprost. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the travoprost profile page.
Complete Access Available with Subscription
Summary for product number 001
|Active Rx/OTC/Discontinued:||DISCN||Dosage:||SOLUTION/DROPS;OPHTHALMIC||Strength||0.003% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**|
|Approval Date:||May 15, 2014||TE:||RLD:||Yes|
|Patent:||8,178,582||Patent Expiration:||Oct 10, 2029||Product Flag?||Y||Substance Flag?||Delist Request?||
|Patent:||8,722,735||Patent Expiration:||Oct 10, 2029||Product Flag?||Y||Substance Flag?||Delist Request?||
|Patent:||8,754,123||Patent Expiration:||May 19, 2029||Product Flag?||Y||Substance Flag?||Delist Request?||
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.